KAST
  • home
  • KAST

Friday (March 1, 2019)

Registration
Opening Ceremony
(08:30-09:30)

Gi Jeong Cheon
Opening, KAST International Symposium
Congratulatory Remarks Myung Chul Lee KAST
Appreciation Plaque for Past Organizers DS Lee/JM Jeong Co-Chairpersons
Opening Remarks JM Jeong & DS Lee Co-Chairpersons
Coffee Break (09:30-10:00) and Exhibition
Keynote 1 (10:00-10:30)
Uncovering Novel Biomarkers for Next Generation Theranostics Sunghoon Kim  Korea
Chair: Dong Soo Lee
Scientific Session 1
(10:30-12:00)
Current Status of Theranostics
Chairs: Clinical Trials Supporting FDA/EMA Approval of Lutathera Tessa Brabander The Netheralands
Kyung Han Lee Clinical Experiences with PSMA-1007: Current Status Kambiz Rahbar Germany
TBD Clinical Experieces of 177Lu PSMA Combined or for Other Cancers Markus Essler Germany
Future Perspectives of Theranostics in Germany Wolfgang Weber Germany
Future Perspectives of Theranostics in USA Richard Wahl USA
Lunch (12:00-13:00)
Poster and Exhibition (13:00-14:00)
Keynote 2 (14:00-14:30)
Practical Applications and Future Prospects of Radiotheranostics Michael Hofman Australia
Chair: Richard Wahl
Scientific Session 2
(14:30-15:30)
Theranostics of Prostate Cancer

Chairs: Unmet Clinical Needs in Advanced Prostate Cancer Cheol Kwak Korea
Gi Jeong Cheon Targeting Non-cullin Neddylation to Combat Neoplastic and Metabolic Diseases Yang-sook Chun Korea
Horacio Amaral Simplest Glu-Urea-Lys (EUK) for PSMA Yun-Sang Lee Korea
Theranostic Agents for Targeting PSMA: Development of 18F and Alpha Emitters Dae Yoon Chi Korea
Reports 1
(15:30-16:00)
Current Status of Theranostics in Asia
Chair: Theranostics in Korea Keon Wook Kang Korea
Keon Wook Kang Theranostics in Japan Seigo Kinuya Japan
Theranostics in China Feng Wang China
Coffee Break (16:00-16:30) and Exhibition
Scientific Session 3-1
(16:30-18:00)
Next Generation Theranostics (from Chemists' Point of View) - Novel Targets and Probes
Chairs: Instant Kit-type Labelling Chemistry for 68Ga, 44Sc, 177Lu. Frank Rösch Germany
Frank Rösch Image Guided Therapy: Development of Oncologic and Non-oncologic Agents Henry VanBrocklin USA
Henry VanBrocklin Potential Use of Hypoxia and Thymidine Phosphorylase Imaging Probes for Theranostics Yuji Kuge Japan
The Heidelberg Series of Glu-ureido based PSMA Tracers: Adaption of Chemical Structure to Clinical Indication Klaus Kopka Germany
Imaging of the Third Gasotransmitter Jae Min Jeong Korea
Organized by
Supported by
Gold
Silver